Launch Excellence VI

Launch Excellence in a disrupted world: challenges and opportunity

White Paper

September 10, 2019
Launch ExcellenceVI
It is now very clear that the global pharmaceutical industry is in a period of significant change, and with it the environment for innovative product launch. Molecular innovation is being supplemented, and in some instances could be replaced, by other forms of innovation, including highly individualised and procedure-like cell and gene therapies, prescription digital therapeutics, or innovation on existing, off-patent molecules.
Webinar Replay
The launch environment has undergone huge changes as the pharmaceutical industry’s focus has moved from primary care to specialty launch, but its future will be transformed even more radically. Register and replay our webinar to find out more.